Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Niraparib + Dostarlimab for Breast Cancer
Recruiting1 awardPhase 2
Seattle, Washington
This trial is studying how well a combination of two drugs works in treating patients with breast cancer that has spread to other parts of the body and have certain genetic mutations
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.